- Home
- VTSI vs BCAB Comparison
VTSI vs BCAB Comparison
Compare VTSI & BCAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VTSI
- BCAB
- Stock Information
- Founded
- VTSI 1993
- BCAB 2007
- Country
- VTSI United States
- BCAB United States
- Employees
- VTSI N/A
- BCAB N/A
- Industry
- VTSI Miscellaneous manufacturing industries
- BCAB Medicinal Chemicals and Botanical Products
- Sector
- VTSI Consumer Discretionary
- BCAB Health Care
- Exchange
- VTSI Nasdaq
- BCAB Nasdaq
- Market Cap
- VTSI 61.9M
- BCAB 71.6M
- IPO Year
- VTSI N/A
- BCAB 2020
- Fundamental
- Price
- VTSI $4.91
- BCAB $0.81
- Analyst Decision
- VTSI Strong Buy
- BCAB Hold
- Analyst Count
- VTSI 1
- BCAB 3
- Target Price
- VTSI $7.00
- BCAB $1.00
- AVG Volume (30 Days)
- VTSI 52.1K
- BCAB 1.9M
- Earning Date
- VTSI 11-10-2025
- BCAB 11-13-2025
- Dividend Yield
- VTSI N/A
- BCAB N/A
- EPS Growth
- VTSI N/A
- BCAB N/A
- EPS
- VTSI 0.01
- BCAB N/A
- Revenue
- VTSI $24,934,267.00
- BCAB N/A
- Revenue This Year
- VTSI $10.31
- BCAB N/A
- Revenue Next Year
- VTSI $12.71
- BCAB N/A
- P/E Ratio
- VTSI $346.31
- BCAB N/A
- Revenue Growth
- VTSI N/A
- BCAB N/A
- 52 Week Low
- VTSI $3.57
- BCAB $0.24
- 52 Week High
- VTSI $8.20
- BCAB $1.74
- Technical
- Relative Strength Index (RSI)
- VTSI 39.68
- BCAB 49.90
- Support Level
- VTSI $4.65
- BCAB $0.70
- Resistance Level
- VTSI $5.04
- BCAB $1.43
- Average True Range (ATR)
- VTSI 0.35
- BCAB 0.19
- MACD
- VTSI -0.02
- BCAB 0.01
- Stochastic Oscillator
- VTSI 23.83
- BCAB 26.20
About VTSI VirTra Inc.
VirTra Inc is a U.S.-based company that is engaged in the sale and development of the judgmental use of force training simulators and firearms training simulators for law enforcement, military, and commercial uses. It sells simulators and related products across the globe through a direct sales force and international distribution partners. The services provided by the company include installation, training, limited warranties, service agreements, and related support. The company sells and supports the use of force training and marksmanship firearms training systems and accessories for law enforcement, military, or civilian use. Company's The product lany includes simulators, upgrade components, scenarios, scenario software, recoil kits, Threat Fire, and other accessories.
About BCAB BioAtla Inc.
BioAtla Inc is a clinical-stage biopharmaceutical company. The company is engaged in the development of a novel class of specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. Its pipeline products comprise mecbotamab vedotin (BA3011), ozuriftamab vedotin (BA3021), and evalstotug (BA3071), and its Phase 1 clinical trial of BA3182 (CAB-EpCAM x CAB-CD3) and Bispecific antibody programs.